Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo

Authors: Harris S.I.; Kuss M.; Hubbard R.C.; Goldstein J.L.1

Source: Clinical Therapeutics, Volume 23, Number 9, September 2001 , pp. 1422-1428(7)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: parecoxib sodium; ketorolac; naproxen; nonsteroidal anti-inflammatory drugs; gastrointestinal toxicity; COX-2 inhibitor

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(01)80117-X

Affiliations: 1: University of Illinois at Chicago, Chicago, Illinois, U.S.A.

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A